PARADISE-24 Questionnaire Needs More Validation and Translations
Researchers studied the PARADISE-24 questionnaire, which is designed to assess how brain disorders affect daily life.
Plain‑language summaries on epilepsy comorbidities explained—ADHD, autism, anxiety, depression, and more—plus practical tips for families.
Researchers studied the PARADISE-24 questionnaire, which is designed to assess how brain disorders affect daily life.
Researchers studied the effects of interictal epileptiform discharges (IEDs) on cognitive functions and reaction times in people with epilepsy.
A study was conducted to compare two medications used to treat seizures: levetiracetam (LEV) and brivaracetam (BRV).
Researchers studied a type of epilepsy called self-limited epilepsy with centrotemporal spikes (SeLECTS) in 192 children.
This study looked at how blocking a specific enzyme called kynurenine-3-monooxygenase (KMO) affects seizures, depression-like behaviors, and thinking abilities in mice with epilepsy.
Researchers studied a type of beneficial bacteria called Akkermansia muciniphila (A.
Researchers studied the effectiveness and safety of two medications, levetiracetam (LEV) and phenobarbital (PB), for treating seizures in newborns.
Researchers studied how much of a brain tumor called glioma should be removed during surgery.
This study looked at the long-term quality of life for people who survived a severe type of epilepsy called new onset refractory status epilepticus (NORSE), including a specific form known as febrile infection-related epilepsy syndrome (FIRES).